NEWS

February 11, 2022

Prota cracks $20m raising for its allergy treatment

MELBOURNE: Australian biotech Prota Therapeutics is chasing $20 million to prepare Phase 3 ... read more

February 11, 2022

Terms out for Microba IPO and investors are not happy

BRISBANE: Gut health biotech Microba’s brokers have blasted the terms of its $30 ... read more

February 11, 2022

Sydney Airport ceases trading on ASX after $23.6b takeover

SYDNEY: Sydney Airport has dropped off the Australian Securities Exchange less than two ... read more

February 11, 2022

MacCap nabs $1.5b mandate to sell Cobham Aviation

SYDNEY: Global services business Cobham is seeking a buyer for its Australian charter ... read more